Mark Miller
Chief Investor Relations Officer
Replay available
Encompass Health Corporation (NYSE: EHC) Q3 2025 earnings conference call, held 2025-10-30. Replay captured from the company's public earnings webcast.

Chief Investor Relations Officer
President and Chief Executive Officer
Analyst, Bank of America Securities
Analyst, Deutsche Bank Securities
Analyst, Mizuho Securities
Analyst, KeyBank
Analyst, Leerink Partners
Analyst, Barclays Capital
Analyst, UBS
Analyst, Jefferies
Analyst, William Blair
Analyst
Please stand by. Your program is about to begin. Should you need audio assistance, you may press star then zero on your telephone keypad to speak with an audio coordinator. Good morning, everyone, and welcome to Encompass Health's third quarter 2025 earnings conference call. At this time, I would like to inform all participants that their lines will be in a listen-only mode. After the speaker's remarks, there will be a question and answer period. If you would like to ask a question during this time, please press star one on your telephone keypad. You'll be limited to one question and one follow-up question. Today's conference call is being recorded. If you have any objections, you may disconnect at this time. I will now turn the call over to Mark Miller, Encompass Health's Chief Investor Relations Officer. Thank you, operator, and good morning, everyone. Thank you for joining Encompass Health's third quarter 2025 earnings call. Before we begin, if you do not already have a copy, The third quarter earnings release supplemental information and related form 8K filed with the SEC are available on our website at encompasshealth.com. On page two of the supplemental information, you will find the safe harbor statements, which are also set forth in greater detail on the last page of the earnings release. During the call, we will make forward-looking statements such as guidance and growth projections, which are subject to risks and uncertainties, many of which are beyond our control. Certain risks and uncertainties, like those relating to regulatory developments, as well as volume, bad debt, and cost trends that could cause actual results to differ materially from our projections, estimates, and expectations are discussed in the company's SEC filings, including the earnings r...